157P Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy.
Saved in:
| Title: | 157P Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy. |
|---|---|
| Authors: | Gorgulho, J.1 (AUTHOR), Loosen, S.H.2 (AUTHOR), Masood, R.3 (AUTHOR), Buescher, G.3 (AUTHOR), Kochheise, L.3 (AUTHOR), Schmidt, C.3 (AUTHOR), Schulze, K.3 (AUTHOR), Sinn, M.1 (AUTHOR), Fritzsche, B.4 (AUTHOR), Altfeld, M.5 (AUTHOR), Peine, S.6 (AUTHOR), Wikman, H.7 (AUTHOR), Huber, S.3 (AUTHOR), Lohse, A.W.3 (AUTHOR), Beier, F.8 (AUTHOR), Brümmendorf, T.H.8 (AUTHOR), Bokemeyer, C.1 (AUTHOR), Lüdde, T.2 (AUTHOR), Von Felden, J.3 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS277-S278. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.165 |
